1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with Malaria, Falciparum in 1 studies
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol: a sphingolipid analog; inhibits the enzyme activity in infected erythrocytes
N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide : A fatty amide resulting from the formal condensation of palmitic acid with the primary amino group of 2-amino-3-(morpholin-4-yl)-1-phenylpropan-1-ol.
Malaria, Falciparum: Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lauer, SA | 1 |
| Ghori, N | 1 |
| Haldar, K | 1 |
1 other study available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and Malaria, Falciparum
| Article | Year |
|---|---|
Sphingolipid synthesis as a target for chemotherapy against malaria parasites.
Topics: Animals; Antimalarials; Enzyme Inhibitors; Erythrocyte Membrane; Erythrocytes; Golgi Apparatus; Huma | 1995 |